Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Pharmac considers funding at-home urine tests for medical abortion follow-up, potentially replacing blood tests.
Pharmac, New Zealand's pharmaceutical funding agency, is considering funding at-home low sensitivity urine tests to confirm the completion of medical abortions, potentially replacing blood tests.
This change aims to improve accessibility, as many individuals currently do not complete follow-up tests.
If approved, about 9,300 people could use the tests in the first year.
Public consultation runs until October 30, with a possible rollout on December 1, 2024.
3 Articles
Pharmac considera la financiación de análisis de orina en el hogar para el seguimiento del aborto médico, potencialmente reemplazando los análisis de sangre.